GlassScriptPhysician profile
Kristy M Maag
NPI 1316334212
$616.72
in general payments reported to CMS, 2019-2025
18 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.88 · 2022: $56.84 · 2023: $128 · 2024: $269 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492 · Education: $17.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.98 |
| Education | $17.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $69.99 | 2024-2025 | Jemperli, Zejula |
| Daiichi Sankyo INC. | $60.93 | 2021-2025 | Enhertu, Injectafer |
| Taiho Oncology, INC. | $55.93 | 2023-2025 | |
| Eisai INC. | $53.63 | 2023-2024 | |
| Puma Biotechnology, INC. | $49.32 | 2023-2025 | |
| Janssen Biotech, INC. | $47.88 | 2023-2024 | Tecvayli |
| Dendreon Pharmaceuticals LLC | $43.97 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $37.66 | 2024 | Libtayo |
| Genentech USA, INC. | $35.44 | 2024 | Lunsumio, Columvi, Polivy |
| Novartis Pharmaceuticals Corporation | $22.97 | 2023 | |
| Pfizer INC. | $20.65 | 2024 | |
| Novocure INC. | $19.85 | 2025 | Optune Gio |
| Pharmacosmos Therapeutics INC. | $19.63 | 2024 | Cosela |
| Janssen Pharmaceuticals, INC | $17.71 | 2023 | Spravato |
| Emmaus Medical, INC. | $17.30 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genmab U.S., INC. | $16.00 | 2024 | Tivdak |
| Celgene Corporation | $14.99 | 2021 | |
| Abbvie INC. | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristy Maag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.